Vanguard Group Inc Acumen Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,934,039 shares of ABOS stock, worth $4.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,934,039

Previous 1,896,949 1.96%

Holding current value

$4.89 Million

Previous $4.59 Million 4.49%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.22 - $3.54 $82,339 - $131,298	37,090 Added 1.96%	1,934,039 $4.8 Million
Q2 2024 Aug 13, 2024	BUY	$2.14 - $4.01 $496,246 - $929,882	231,891 Added 13.93%	1,896,949 $4.59 Million
Q1 2024 May 10, 2024	SELL	$2.97 - $4.64 $518,247 - $809,652	-174,494 Reduced 9.49%	1,665,058 $6.74 Million
Q4 2023 Feb 14, 2024	SELL	$1.86 - $4.48 $31,620 - $76,160	-17,000 Reduced 0.92%	1,839,552 $7.06 Million
Q3 2023 Nov 14, 2023	BUY	$4.15 - $9.72 $4.66 Million - $10.9 Million	1,121,700 Added 152.64%	1,856,552 $7.7 Million
Q2 2023 Aug 14, 2023	BUY	$3.59 - $6.59 $412 - $757	115 Added 0.02%	734,852 $3.53 Million
Q1 2023 May 15, 2023	BUY	$3.75 - $6.65 $70,875 - $125,685	18,900 Added 2.64%	734,737 $2.98 Million
Q4 2022 Feb 10, 2023	BUY	$4.81 - $10.17 $311,644 - $658,924	64,791 Added 9.95%	715,837 $3.87 Million
Q3 2022 Nov 14, 2022	BUY	$4.44 - $10.48 $67,785 - $159,998	15,267 Added 2.4%	651,046 $6.53 Million
Q2 2022 Aug 12, 2022	SELL	$3.08 - $4.88 $1.84 Million - $2.92 Million	-598,992 Reduced 48.51%	635,779 $2.99 Million
Q1 2022 May 13, 2022	BUY	$3.91 - $6.73 $2.66 Million - $4.58 Million	679,798 Added 122.49%	1,234,771 $4.83 Million
Q4 2021 Feb 14, 2022	SELL	$6.54 - $15.31 $5.04 Million - $11.8 Million	-769,925 Reduced 58.11%	554,973 $3.75 Million
Q3 2021 Nov 12, 2021	BUY	$14.5 - $20.28 $19.2 Million - $26.9 Million	1,324,898 New	1,324,898 $19.7 Million

Others Institutions Holding ABOS

# of Institutions

Shares Held

41.7M

Call Options Held

57.7K

Put Options Held

70.6K

View Full List

About Acumen Pharmaceuticals, Inc.

Ticker ABOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,503,100
Market Cap $102M
Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...

More about ABOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Acumen Pharmaceuticals, Inc. Transaction History